Design and Evaluation of Favipiravir Loaded Mouth Dissolving Tablets - Nadendla, Prof. Rama Rao;Gudipati, Dr. Madhu;Avinash, D
39,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Broschiertes Buch

The concept of formulation favipiravir mouth dissolving tablets is to offer a suitable approach for improving patient compliance in pediatrics, geriatrics and children, thereby avoiding side effects such as nausea and gastritis. In the present work, MDT of favipiravir was prepared successfully by wet granulation technique using super disintegrants. The different concentrations and combinations of super disintegrants such as CCS, SSG and CPV. From the experimental results, it can be concluded that pre-formulation studies like solubility and UV-analysis were complied with standards. The FT-IR…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The concept of formulation favipiravir mouth dissolving tablets is to offer a suitable approach for improving patient compliance in pediatrics, geriatrics and children, thereby avoiding side effects such as nausea and gastritis. In the present work, MDT of favipiravir was prepared successfully by wet granulation technique using super disintegrants. The different concentrations and combinations of super disintegrants such as CCS, SSG and CPV. From the experimental results, it can be concluded that pre-formulation studies like solubility and UV-analysis were complied with standards. The FT-IR spectra revealed that, there was no interaction between favipiravir and polymers. All the polymers used were compatible with favipiravir.However, the disintegration time for each formulation was not significantly affected by super disintegrants concentration. The study also indicated about the amount of drug release is also altered by super disintegrant concentration. Different super disintegrants have shown significant results while performing in-vitro studies.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Madhu Gudipati has completed his Ph.D. at the Faculty of Pharmaceutical Sciences under the guidance of Prof. Rama Rao Nadendla, Principal, Chalapathi Institute of Pharmaceutical Sciences (Autonomous), Acharya Nagarjuna University, Andhra Pradesh, India. He is qualified in UGC-RGNF Fellowship awarded as JRF & SRF for research in AY2013.